SBI-553 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets NTR1.
Molecular Weight
450.56
Molecular Formula
C26H31FN4O2
Targets
NTR1
Form
Lyophilized powder
Purity
>98%
Applications
SBI-553 can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
